Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have been diagnosed with a type of blood cancer called diffuse large B-cell lymphoma (DLBCL).
- For Group 1: People with a confirmed DLBCL diagnosis for whom the treating doctor has determined that starting treatment is appropriate.
- For Group 2: People with a confirmed DLBCL diagnosis whose cancer has not responded to, or has come back after, at least one previous treatment.
- People who are willing to sign a consent form showing they understand what the study involves and what will be required of them.
Who may not be able to join:
- People for whom the treating doctor has determined that treatment is not appropriate for any reason.
- People who currently have another active cancer in addition to DLBCL.
- People who are currently taking part in another clinical trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-877-240-9479
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To describe the treatment patterns for the first line and subsequent therapies for DLBCL patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.